CHENGYIPHARMA: Ethyl Eicosapentaenoate Soft Capsules have obtained the drug registration certificate
I'm PortAI, I can summarize articles.
CHENGYIPHARMA announced that its eicosapentaenoic acid ethyl ester soft capsules have obtained the drug registration certificate from the National Medical Products Administration. This drug is used to lower triglyceride levels in adult patients with severe hypertriglyceridemia based on dietary control and can be used in conjunction with statins to reduce the risk of cardiovascular events. The impact on the risk of pancreatitis in patients with severe hypertriglyceridemia has not yet been assessed
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments